Research & Development



  這具尸體的腦袋耷拉著,一柄長刀刺穿了他的身體,將他牢牢地固定在樹干上。   孩子是大長秋架在雲瑯脖子上的,是阿嬌直接指揮的。一本道高清无码v   此事發生的如此急促,恰恰又是在皇後駕臨雲氏的前一天,其用意算是不說自明。一本道久久综合久久爱DVD色色   雲瑯見到何愁有一腳踹翻何玉樹的場面,那一腳踹的很重,身形高大的何玉樹被踹的飛了起來,一點自我保護意識都沒有的摔進了迎春花叢里。   雲瑯笑道︰“應該把錢盡快的變成新的產業,比如您得富貴城就是一個極大的產業。不知道貴人發現了沒有,因為您在富貴城不斷地花錢,如今的富貴縣要比其余的郡縣富裕的多?”无码av高清毛片在线看   來到一個三面都被松樹包圍的死角里,雲瑯這才松開了霍光的嘴巴,生氣的道︰“你怎麼來了?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo